2022 CVS Caremark DOAC non-medical switch: Patient ramifications and physician advocacy

被引：0
|
作者：
Patel, Kushal D. [1 ,2 ]
Patel, Dharmesh [3 ,4 ]
Deison, Hunt [4 ]
Gough, Ryan [4 ]
机构：
[1] Memphis Univ Sch, Memphis, TN 38119 USA
[2] Woodberry Associates, Washington, DC 20006 USA
[3] Stern Cardiovasc Fdn, Memphis, TN USA
[4] Partnership Adv Cardiovasc Hlth, Washington, DC USA
来源：
AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2024年 / 20卷
关键词：
D O I：
10.1016/j.ajpc.2024.100870
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Expert information of the TK MG Non-medical electrical Devices in the Patient Environment
    不详
    ELEKTROTECHNIK UND INFORMATIONSTECHNIK, 2008, 125 (03): : A16 - A16
  • [32] Outcomes of a mandatory non-medical switch of infliximab to a biosimilar for inflammatory bowel disease in British Columbia, Canada
    Hoang, Thomas Tam
    Reid, Jacqueline
    Galorport, Cherry
    Bressler, Brian
    Leung, Yvette
    Rosenfeld, Greg
    JOURNAL OF THE CANADIAN ASSOCIATION OF GASTROENTEROLOGY, 2024, 7 (04) : 299 - 305
  • [33] The Impact of a Forced Non-Medical Switch of Inhaled Respiratory Medication Among Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Patient Survey on Experience with Switch, Therapy Satisfaction, and Disease Control
    Gilbert, Ileen
    Wada, Keiko
    Burudpakdee, Chakkarin
    Ghai, Chirag
    Tan, Laren
    PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 1463 - 1475
  • [34] Patient Survey Regarding Non-Medical Burdens of Care at a Parental Fetal Care Center
    Gregory, Emily J.
    Abbasi, Aleeza H.
    Markham, Kara B.
    JOURNAL OF PATIENT EXPERIENCE, 2024, 11
  • [35] Non-medical switching in dermatology: cost-conscious policy or an affront to patient safety?
    Patel, Palak V.
    Purvis, Caitlin G.
    Hamid, Ramiz N.
    Feldman, Steven R.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (06) : 2707 - 2710
  • [36] ARE COMORBIDITIES IN PATIENTS WITH CHRONIC INFLAMMATORY RHEUMATIC DISEASES ASSOCIATED WITH TREATMENT NON-ADHERENCE TO BIOSIMILARS IN A NON-MEDICAL SWITCH SCENARIO?
    Redeker, I.
    Moustakis, S.
    Tsiami, S.
    Baraliakos, X.
    Andreica, I.
    Buehring, B.
    Braun, J.
    Kiltz, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1805 - 1806
  • [37] Patient attitudes about non-medical switching to biosimilars: results from an online patient survey in the United States
    Teeple, A.
    Ginsburg, S.
    Howard, L.
    Huff, L.
    Reynolds, C.
    Walls, D.
    Ellis, L. A.
    Curtis, J. R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (04) : 603 - 609
  • [38] IMPACT OF A NON-MEDICAL SWITCH FROM TOCILIZUMAB TO UPADACITINIB IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN ROUTINE CLINICAL PRACTICE
    White, Douglas
    Poppelwell, David
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 34 - 34
  • [39] NON-MEDICAL MANDATORY REVERSED AND BACK AND FORTH SWITCH BETWEEN INFLIXIMAB AND ITS BIOSIMILAR: EARLY CLINICAL OUTCOMES
    Ilias, Akos
    Szanto, Kata
    Gonczi, Lorant
    Kurti, Zsuzsanna
    Golovics, Petra Anna
    Szamosi, Tamas
    Schafer, Eszter
    Farkas, Klaudia
    Szepes, Zoltan
    Molnar, Tamas
    Vincze, Aron
    Lakatos, Peter L.
    GASTROENTEROLOGY, 2018, 154 (06) : S822 - S822
  • [40] Non-medical mandatory reversed and back and forth switch between infliximab and its biosimilar: Early clinical outcomes
    Ilias, A.
    Szanto, K.
    Gonczi, L.
    Kurti, Z.
    Golovics, P. A.
    Schafer, E.
    Farkas, K.
    Szamosi, T.
    Szepes, Z.
    Molnar, T.
    Vincze, A.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S461 - S462
12345